Efficacy and safety of original EGFR-TKI combined with bevacizumab in advanced lung adenocarcinoma patients harboring EGFR-mutation experiencing gradual progression after EGFR-TKI treatment: a single-arm study

Long, JL; Lei, SY; Wu, ZJ; Xiong, SL; Wang, CM; Huang, LM; Liang, GZ; Yang, D; Teng, Y; Li, YS; Qi, J; Li, DR

Li, DR (通讯作者)，Chongqing Univ, Dept Med Oncol, Canc Hosp, Chongqing 400030, Peoples R China.;Qi, J; Li, DR (通讯作者)，Chongqing Canc Inst, Chongqing 400030, Peoples R China.;Qi, J; Li, DR (通讯作者)，Chongqing Canc Hosp, Chongqing 400030, Peoples R China.;Qi, J (通讯作者)，Chongqing Univ, Dept Thorac Surg, Canc Hosp, Chongqing 400030, Peoples R China.

ANNALS OF TRANSLATIONAL MEDICINE, 2022; 10 (24):

Abstract

Background: Keeping on original epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment is the standard treatment for gradual ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索